Literature DB >> 32894520

MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.

R-S Wu1, E-H Qiu, J-J Zhu, J-R Wang, H-L Lin.   

Abstract

The article "MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway, by R.-S. Wu, E.-H. Qiu, J.-J. Zhu, J.-R. Wang, H.-L. Lin, published in Eur Rev Med Pharmacol Sci 2018; 22(1): 150-157-DOI: 10.26355/eurrev_201801_14112-PMID: 29364482" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/14112.

Entities:  

Year:  2020        PMID: 32894520     DOI: 10.26355/eurrev_202008_22580

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma.

Authors:  Li Sun; Mu Xu; Guoying Zhang; Lin Dong; Jie Wu; Chenchen Wei; Kexin Xu; Lu Zhang
Journal:  Int J Genomics       Date:  2021-12-27       Impact factor: 2.326

2.  Aberrant miR-362-3p is Associated with EBV-Infection and Prognosis in Nasopharyngeal Carcinoma and Involved in Tumor Progression by Targeting JMJD2A.

Authors:  Xiangyun Wang; Ping Chen
Journal:  Onco Targets Ther       Date:  2022-01-28       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.